Farnesyl-Di-Methyl-Chromanol (DeMelle OncoPharma)

N/A

Report date: 2024/11/19 10:59:27
NMEFirst In Class

Base Information

Drug NameFarnesyl-Di-Methyl-Chromanol (DeMelle OncoPharma)
Drug Alias NameDM-3001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExportin-2 protein modulators
TargetsExportin-2 protein
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDeMelle OncoPharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesDeMelle OncoPharma LLC
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A